家族性高胆固醇血症
载脂蛋白B
先证者
低密度脂蛋白受体
PCSK9
突变
遗传学
基因
内科学
生物
等位基因
外显子
胆固醇
基因突变
脂蛋白
内分泌学
医学
作者
Lukáš Tichý,Lenka Fajkusová,Petra Zapletalová,Lucie Schwarzová,Michal Vráblík,Tomáš Freiberger
出处
期刊:Physiological Research
[Institute of Physiology of the Czech Academy of Sciences]
日期:2017-04-15
卷期号:: S47-S54
被引量:12
标识
DOI:10.33549/physiolres.933587
摘要
Autosomal dominant hypercholesterolemia (ADH), more known as familial hypercholesterolemia (FH), is a lipid metabolism disorder characterized by an elevation in low-density lipoprotein cholesterol (LDL-C) and increased risk for cardiovascular disease. In this study, we assessed a spectrum of mutations causing ADH in 3914 unrelated Czech patients with clinical diagnosis of hypercholesterolemia. Samples have been collected within the framework of the MedPed project running in the Czech Republic since 1998. So far we have found 432 patients (11.0 %) with the APOB gene mutation p.(Arg3527Gln) and 864 patients (22.1 %) with the LDLR gene mutation. In 864 probands carrying the LDLR gene mutation, 182 unique allelic variants were detected. We have identified 14 patients homozygous for mutations in the LDLR or APOB genes. We performed function analyses of p.(Leu15Pro) and p.(Gly20Arg) sequence variations.
科研通智能强力驱动
Strongly Powered by AbleSci AI